Timely insulin therapy to treat type 2 diabetes

Timely insulin therapy to treat type 2 diabetes

Diabetes is a tricky condition to treat. While insulin can efficiently lower blood sugar levels and protect pancreatic ꞵ-cells, it can also cause harmful side effects such as hypoglycaemia and weight gain. Severe hypoglycaemia may trigger arrhythmias and cardiovascular events. Professor Markolf Hanefeld suggests that an individualised approach to start timely insulin therapy on the basis of risk/benefit balance is […]

Read More…

Flexibility is key in treating children with type 1 diabetes

Blood vessels

People with type 1 diabetes cannot produce their own insulin, leading to uncontrolled blood sugar levels. To survive, they must receive insulin treatment. A recently developed, long-lasting insulin called degludec offers a unique level of flexibility. This means that it is particularly suitable for treating children and young people with type 1 diabetes. Dr Nandu Thalange, an expert in childhood diabetes […]

Read More…

Diabetes treatment: Could carbonates be an alternative?

Diabetes testing

Diabetes affects millions of adults worldwide and is still a disease without a cure. While injections of insulin can help manage symptoms, there are currently no therapies to treat the underlying cause of diabetes. However, Dr Kenji Sorimachi has found that perhaps the answer lies in the form of carbonate complexes that show an ability to metabolise carbohydrates into glucose […]

Read More…

Thank you for expressing interest in joining our mailing list and community. Below you can select how you’d like us to interact with you and we’ll keep you updated with our latest content.

You can change your preferences or unsubscribe by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at audience@researchoutreach.org at any time and if you have any questions about how we handle your data, please review our privacy agreement.

Would you like to learn more about our services?

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.

Subscribe to our FREE PUBLICATION